Navigation Links
GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.

ProductsGeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.
Company GeneChoice, Inc.
Item GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor
Price $142.00
Description Ribonuclease Inhibitor is a recombinant protein that has been shown to help maintain the integrity of RNA in the preparation of cDNA by reverse transcription, in vitro RNA transcription, and in vitro protein synthesis. RNA Safe Inhibitor tightly binds RNases in a 1:1 ratio. It inhibits a broad range of eukaryotic RNases such as RNase A, RNase B, RNase C, and human placental RNase. RNA Safe does not interfere with the performance of other enzymes in the reaction. • RNA Safe is most effective between pH 5.5 and 8.0. It does not inhibit AMV or MMLV reverse transcriptases; SP6, T3, and T7 RNA polymerases; Taq DNA polymerase; RNase H; RNase T1; or S1 Nuclease. • Efficient inhibition of ribonucleases •Protects RNA during cDNA synthesis and in vitro transcription/translation.

  • Applications: First and second strand cDNA synthesis, RT-PCR, and in vitro transcription and translation.
  • Unit Definition: One unit of protein inhibits the activity of 5 ng RNase A by 50%.
  • Enzyme Concentration: 40 to 50 units/µl.
  • Supplied As: 5,000 units.
  • Storage Conditions: Store at -20°C.
Info GeneChoice, Inc.GeneChoice, Inc.
7307 Governors Way
Frederick, MD 21703 USA

Call GeneChoice, Inc. to buy products (US and Canada only; other locations use numbers below)
USA Canada 1-866-772-8354
Customer Service: 866-636-2200
Fax Number: 301-620-0162
Web Site: http://www.genechoiceinc.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. GeneChoice Taq DNA Polymerase With Standard Buffer from GeneChoice, Inc.
2. GeneChoice Taq DNA Polymerase With Ammonium Buffer from GeneChoice, Inc.
3. GeneChoice Taq DNA Polymerase With Magnesium Free Standard Buffer from GeneChoice, Inc.
4. GeneChoice TEMPase II DNA Polymerase from GeneChoice, Inc.
5. Recombinant Expression of Peptides and Proteins: from rPeptide, LLC
6. Recombinant RNasin® Ribonuclease Inhibitor from Promega
7. RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
8. hKv4.2/hKChIP2-CHO K1 Recombinant Cell Line from Upstate
9. hERG-CHO K1 Recombinant Cell Line from Upstate
10. hERG-CHO K1 Recombinant Cell Line from Upstate
11. hHCN4-CHO K1 Recombinant Cell Line from Upstate
Porcine Pulmonary Artery Endothelial Cells (PPAEC) (>500,000 cells)...
... fluorescent and highly photostable FluoSpheres microspheres ... a variety of applications requiring probes ... Unfortunately, protein- and other macromolecule-labeled microspheres ... them to bind to non-target surfaces ...
SMVT (N-14)...
... a fully licensed, high throughput, water bath thermal ... to 24 microplates. This equates to 9,216 reactions ... A robotic arm rapidly transfers a basket of ... ramping times that are considerably faster than those ...
Biology Products:
(Date:6/19/2019)... ... June 19, 2019 , ... Dahryn Trivedi, today released research results on ... antibiotic which can prove to be beneficial for treating multiple bacterial diseases. , The ... , Over 68% decrease in weight , Over 8% ...
(Date:6/16/2019)... , ... June 14, 2019 , ... ... Oracle Cloud customer, will deliver a joint presentation with Versiti’s CIO at the ... 16-19 at the Rosen Shingle Creek Resort. , Versiti Vice President and Chief ...
(Date:6/13/2019)... (PRWEB) , ... June 13, 2019 , ... ... , the first organization exclusively serving the end-to-end clinical and ancillary supply chain ... well as contract and medical research organizations, today announced it will sponsor a ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... 2019 , ... A study released today in STEM CELLS ... to incorporate into human CD34+ cells, modifying their gene expression and increasing their ... cells’ ability to lodge into bone marrow. This research performed by Prof. Sanchez-Guijo’s ...
(Date:5/31/2019)... ... , ... For many years, the primary forms of cancer treatment have been ... in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR T) ... known as “CARs”. The CAR enables the final product to produce chemicals in the ...
(Date:5/31/2019)... ... May 30, 2019 , ... ... Data Integrity on July 08-09, 2019 in Boston, MA. This peer recommended interactive ... device organizations. , The training will kick off with a compendial treatment of ...
(Date:5/31/2019)... ... May 30, 2019 , ... A study ... efficient delivery system for the sustained release of human placental stem cell (HPSC)-derived ... was able to deliver CM into the injured kidney, where it helped restore ...
Breaking Biology Technology: